"The Tumor Microenvironment in Pancreas Cancer Promotes Treatment Resistance"
March 28, 2018
"Radiation Oncology at a Crossroads: Harmonizing Biology with Technology"
March 21, 2018
"Opportunities for Overcoming Radioresistance and Developing Personalized Molecularly-Driven Radiotherapy"
March 14, 2018
"Therapy-Related Myeloid Neoplasms: When Genetics and Environment Collide"
March 7, 2018
Jonathon B. Cohen, MD, MS, of Winship Cancer Institute of Emory University
"Current Approaches to Evaluation and Management of Mantle Cell Lymphoma"
February 7, 2018
Thomas E. Stinchcombe, MD, of Duke University School of Medicine
"Targeted Therapy in Non-Small Cell Lung Cancer"
December 20, 2017
Joseph O. Deasy, PhD, of Memorial Sloan Kettering cancer Center
"Predicting Radiotherapy Outcomes using Clinical Imaging and Genomic Factors"
December 13, 2017
Geoffrey Hugo, PhD, of Washington University School of Medicine in St. Louis
"Adaptive Radiation Therapy for Lung Cancer"
December 6, 2017
Julie M. Vose, MD, MBA, of University of Nebraska Medical Center
"Update on Novel Therapies for Non-Hodgkin Lymphoma"
November 29, 2017
Mia M. Gaudet, PhD, of Rollins School of Public Health
"The Genetics of Breast Cancer from Rare to Common"
November 8, 2017
The Emory University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The Emory University School of Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.